Advertisement
Advertisement
U.S. Markets open in 1 hr 54 mins
Advertisement
Advertisement
Advertisement
Advertisement

BioLife Sciences Inc. (BLFE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.0300+0.1160 (+12.69%)
At close: 03:59PM EST
Advertisement

BioLife Sciences Inc.

5285 Bradco Blvd
Unit B
Mississauga, ON L4W 2A6
Canada
833-919-1037
https://www.biolifesciences.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Justin De FourFounder, CEO & ChairmanN/AN/AN/A
Mr. Colton De GooyerDirector of OperationsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. It offers disinfecting wipes, UV sterilization technology, electrostatic disinfection services, anti-microbial textiles, and touchless vending/marketplaces products. Bio Life Sciences Corp. was incorporated in 2018 and is based in Mississauga, Canada.

Corporate Governance

BioLife Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement